trending Market Intelligence /marketintelligence/en/news-insights/trending/-n1r3eWuqmW_y4YyaMDPAQ2 content esgSubNav
In This List

Great Basin makes 510(k) submission to US FDA for whooping cough test

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Great Basin makes 510(k) submission to US FDA for whooping cough test

Great Basin Scientific Inc. made a 510(k) submission to the U.S. FDA for its bordetella direct test.

The company's sample-to-result test detects bordetella pertussis, commonly known as whooping cough, identifying the bacterium behind the highly contagious respiratory disease.

Great Basin is also seeking a CE mark for the test.